고(高) 호모시스테인, 위험한가요? 원인과 검사실 단서

카테고리
조항
호모시스테인 검사 해석 2026년 업데이트 환자 친화적

High homocysteine can be dangerous when it is persistent, above 15 µmol/L, or paired with B12 deficiency, kidney impairment, clotting history or family risk. A single borderline result is usually a clue, not a diagnosis.

📖 약 11분 📅
📝 게시됨: 🩺 의학적 검토: ✅ 근거 기반
⚡ 간단한 요약 v1.0 —
  1. Normal homocysteine is usually about 5–15 µmol/L in adults, but some European labs flag values above 10–12 µmol/L.
  2. 경미한 상승 from 15–30 µmol/L often points to B12, folate, B6, thyroid, kidney, diet or medication factors.
  3. 중등도 상승 from 30–100 µmol/L deserves a structured review, especially if eGFR is low or MMA is high.
  4. 심한 상승 above 100 µmol/L is unusual and can suggest inherited homocysteine disorders or profound vitamin pathway disruption.
  5. High homocysteine symptoms are usually absent; symptoms more often come from B12 deficiency, anemia, nerve injury or clotting events.
  6. Follow-up markers that separate causes include active B12, methylmalonic acid, RBC folate, creatinine/eGFR, cystatin C, urine ACR, TSH and a medication review.
  7. 치료 should target the cause; B vitamins lower the number, but large trials did not show reliable heart attack prevention in all adults.
  8. 재검 시점 is commonly 8–12 weeks after vitamin or medication changes, using the same lab when possible.

When high homocysteine becomes a real clinical concern

High homocysteine is potentially dangerous when it stays above 15 µmol/L, rises above 30 µmol/L, or appears with kidney disease, low B12 markers, clotting history, early stroke, pregnancy loss, or strong family risk. In clinic, I treat a borderline 13–16 µmol/L result very differently from a repeated 45 µmol/L result with numb feet and a high methylmalonic acid. For baseline ranges, our 호모시스테인 범위 가이드에서 다룹니다. explains why lab cutoffs differ.

Clinician view of homocysteine metabolism asking is high homocysteine dangerous
그림 1: Homocysteine becomes meaningful when interpreted with vitamin, kidney and vascular context.

칸테스티는 AI 혈액검사 분석기 that reads homocysteine alongside B12, folate, MCV, creatinine, eGFR, thyroid markers and cardiovascular risk signals rather than treating one value as a verdict. That pattern matters because a 19 µmol/L result from vegan diet and low active B12 has a different risk story than 19 µmol/L in stage 3 chronic kidney disease.

As Thomas Klein, MD, I have seen patients panic over 12.8 µmol/L because the lab marked it red, then ignore an eGFR of 52 mL/min/1.73 m² sitting beside it. The homocysteine number is a smoke alarm; the follow-up panel tells us whether the smoke is coming from vitamin metabolism, renal clearance, medication effects or a rare inherited pathway.

The practical answer to is high homocysteine dangerous is this: it can be, but the danger is rarely from the number alone. Persistent elevation above 15 µmol/L deserves interpretation, above 30 µmol/L deserves follow-up, and above 100 µmol/L should trigger specialist evaluation rather than supplement guessing.

What level of homocysteine is dangerous in adults?

A homocysteine level above 15 µmol/L is generally elevated, above 30 µmol/L is more concerning, and above 100 µmol/L is a red-flag range for severe metabolic disturbance. Some laboratories use narrower reference intervals, so the pattern and the repeat result matter more than the printed flag. If your result feels borderline, compare it with the principles in our 정상 범위 안내서.

Reference range scene explaining is high homocysteine dangerous across result bands
그림 2: Risk rises most clearly when homocysteine is persistent, repeated or very high.

대부분의 성인 검사실은 5–15 µmol/L as a typical fasting reference range, although I see cutoffs of 10, 12 and 14 µmol/L depending on country and assay. That variability is why a result of 14.6 µmol/L should not be interpreted like a potassium of 6.6 mmol/L; it is a risk clue, not an emergency value.

A value between 15 and 30 µmol/L often reflects remediable physiology: low B12 intake, poor absorption, folate insufficiency, low B6, hypothyroidism, smoking, coffee intake, reduced renal clearance or medication interference. In my experience, this band is where the most useful detective work happens.

Values above 30 µmol/L are not automatically catastrophic, but they are too high to dismiss if repeated. A level above 100 µmol/L is uncommon in ordinary nutrition deficiency and should raise the possibility of inherited homocystinuria, severe B12 pathway disruption, nitrous oxide exposure or combined kidney and vitamin problems.

를 통해 검토용으로 업로드할 수 있습니다. 5–15 µmol/L Usually acceptable, though risk interpretation changes with age, pregnancy status, kidney function and B12 markers.
경미한 상승 15–30 µmol/L Commonly linked with vitamin status, medications, thyroid function, renal clearance or lifestyle factors.
중등도 상승 30–100 µmol/L Needs repeat testing and a cause-focused panel, especially with neurological symptoms or vascular history.
심한 상승 >100 µmol/L Suggests major metabolic disruption and usually warrants specialist assessment.

High homocysteine causes when routine labs look normal

High homocysteine causes can hide behind normal routine labs because CBC, liver enzymes and serum B12 may stay in range while methylation, absorption or renal clearance is already strained. A standard panel can miss early B12 functional deficiency, subtle kidney filtration loss and medication-induced vitamin depletion. Our 종합 패널 가이드 shows why many routine panels do not include the decisive markers.

Routine panel comparison asking is high homocysteine dangerous despite normal labs
그림 3: Routine chemistry can look normal while methylation markers already drift.

A normal hemoglobin of 14.2g/dL and an MCV of 89 fL인 do not rule out early B12-related homocysteine elevation. Neurological B12 effects can appear before anemia, and serum B12 can look acceptable while active B12 delivery to tissues is poor.

Kidney effects can be equally quiet. Homocysteine rises as renal clearance falls, and a creatinine of 1.05 mg/dL can look ordinary in a small older adult while the eGFR is already below 60 mL/min/1.73 m².

Then there is the common medication story: metformin, proton pump inhibitors, anti-seizure drugs, methotrexate, levodopa and nitrous oxide can all shift homocysteine pathways. I ask about these before discussing genetics because medication effects are far more common than classic homocystinuria.

Vitamin-related patterns: B12, folate, B6 and riboflavin

Vitamin-related homocysteine elevation usually reflects impaired remethylation or transsulfuration, most often involving B12, folate, B6 or riboflavin. The most useful separation test is often methylmalonic acid, because high MMA points more strongly toward B12 deficiency than folate deficiency. For difficult B12 cases, see our 활성 B12 가이드.

B12 folate cycle image for is high homocysteine dangerous follow-up testing
그림 4: B12, folate and B6 affect different exits from the homocysteine cycle.

B12 helps convert homocysteine back into methionine, so low B12 often raises both 호모시스테인 그리고 메틸말론산. A serum B12 of 280 pg/mL may be called normal, but if MMA is above 0.40 µmol/L and symptoms fit, I take the functional deficiency seriously.

Folate deficiency tends to raise homocysteine with a normal MMA, although mixed deficiencies are common after restrictive diets, bariatric surgery or gut disease. RBC folate is slower-moving than serum folate and can be useful when last week’s multivitamin makes the serum result look falsely reassuring; our RBC folate guide 그 구분에 대해 더 깊이 들어갑니다.

B6 matters because it helps move homocysteine down the transsulfuration route toward cysteine. I am cautious with high-dose B6: chronic intakes above 100–200 mg/day can cause neuropathy in susceptible people, which is awkward when the patient already came in with tingling.

Medication and lifestyle causes that push homocysteine up

Medication-related high homocysteine is common with long-term metformin, proton pump inhibitors, anti-seizure medicines, methotrexate, levodopa and nitrous oxide exposure. Lifestyle contributors include smoking, heavy coffee intake, low protein quality, low leafy-green intake and high alcohol use. Long-term acid suppression is especially relevant, and we cover monitoring in our PPI lab guide.

Medication review scene for is high homocysteine dangerous and vitamin depletion
그림 6: Medication history often explains an elevated result before genetics does.

Metformin can reduce B12 absorption over time, particularly after 4 or more years of use or at doses of 1,500–2,000 mg/day. If homocysteine rises after starting therapy, the next step is not stopping metformin; it is checking B12 status properly, as outlined in our 메트포르민 검사 가이드는.

Nitrous oxide is the one exposure I ask about very directly because it can inactivate B12 and produce neurological symptoms with a deceptively normal serum B12. I have seen homocysteine above 50 µmol/L after repeated recreational exposure, sometimes with gait instability before anemia appears.

Smoking and high alcohol intake can raise homocysteine by affecting oxidative stress, folate status and liver handling of methyl groups. A patient who smokes 15 cigarettes daily and drinks heavily on weekends may need a very different plan from someone with celiac disease and poor absorption.

Inherited homocysteine risk patterns: MTHFR and beyond

Inherited homocysteine disorders matter most when levels are very high, start early in life, cluster in families, or occur with unusual clotting, lens problems, developmental history or skeletal features. Common MTHFR variants are not the same as classic homocystinuria. For family pattern thinking, our 유전성 지표 가이드는 gives a practical framework.

Family risk pattern illustrating is high homocysteine dangerous in inherited cases
그림 7: Inherited patterns are suspected from level, age of onset and family clustering.

The common MTHFR C677T variant can modestly affect folate handling, but it usually does not produce homocysteine of 80–150 µmol/L by itself in folate-replete adults. I worry more when the biochemical pattern and clinical history fit, not when a direct-to-consumer genotype appears in isolation.

Classic cystathionine beta-synthase deficiency often produces very high total homocysteine and may show elevated methionine. Severe untreated cases can involve thrombosis, lens dislocation, osteoporosis and developmental differences, often long before routine adult preventive screening begins.

Family history changes the threshold for action. If a sibling had a venous clot at age 28, a parent had stroke before 50, or there have been recurrent pregnancy losses, a homocysteine of 22 µmol/L feels more clinically relevant than the same value in a low-risk 70-year-old with stable kidney disease.

High homocysteine symptoms: what patients actually feel

High homocysteine symptoms are usually absent; people feel symptoms from the cause or complication, not from homocysteine circulating quietly in the background. B12 deficiency may cause numbness, burning feet, memory changes, mouth soreness or anemia even when homocysteine is only mildly elevated. Our guide to 빈혈이 없는 B12 결핍 explains this common mismatch.

Nerve symptom pathway for is high homocysteine dangerous in B12 deficiency
그림 8: Symptoms often come from B12-related nerve effects, not the lab value itself.

The symptom pattern I take seriously is tingling in both feet, balance trouble, new cognitive fog, glossitis or unexplained fatigue with homocysteine above 15 µmol/L and borderline B12. A normal hemoglobin does not make those symptoms harmless.

Vascular complications feel different: one-sided weakness, chest pressure, sudden breathlessness, calf swelling or sudden vision loss are urgent symptoms regardless of the homocysteine number. Those presentations need emergency care, not an 8-week supplement experiment.

Patients with numbness often arrive after months of normal routine labs. If the symptom is sensory, symmetrical and progressive, I usually want active B12, MMA, glucose or HbA1c, TSH and sometimes copper; our 저림 검사 가이드 covers that wider differential.

Heart, stroke and clot risk: what the evidence really says

High homocysteine is associated with higher vascular risk, but lowering homocysteine with B vitamins has not consistently lowered heart attack or stroke rates in large trials. That distinction is where many online explanations become too simplistic. The Homocysteine Studies Collaboration reported vascular associations in JAMA in 2002, but association is not proof that every supplement-lowered value prevents events.

Vascular risk diagram asking is high homocysteine dangerous for heart and stroke
그림 9: Homocysteine is one vascular clue, not a stand-alone heart-risk score.

In practice, I read homocysteine beside ApoB, non-HDL cholesterol, LDL-C, blood pressure, HbA1c, kidney markers, smoking status and family history. A homocysteine of 18 µmol/L with ApoB 130 mg/dL를 넘으면 is a different prevention conversation from 18 µmol/L with optimal lipids and no vascular history.

Lonn et al. reported in the 2006 NEJM HOPE-2 trial that folic acid plus vitamins B6 and B12 lowered homocysteine but did not significantly reduce the composite of cardiovascular death, myocardial infarction and stroke in the full high-risk cohort. The result did suggest fewer strokes, yet the overall message was not “B vitamins prevent heart attacks for everyone.”

For inherited lipid risk, homocysteine is not a replacement marker. If early heart disease runs in the family, I would rather combine it with markers such as ApoB and Lp(a); our 높은 Lp(a) 가이드 explains why inherited vascular risk can hide behind a normal routine cholesterol panel.

Follow-up markers that separate vitamin, kidney and inherited patterns

The best follow-up panel for high homocysteine includes active B12 or holotranscobalamin, methylmalonic acid, folate status, B6 where available, CBC indices, creatinine/eGFR, cystatin C, urine ACR, TSH and medication review. 칸테스티는 AI 혈액검사 결과 해석 플랫폼 that groups these markers by likely cause rather than listing them as separate red and green flags. Our biomarker guide maps many of these markers in one place.

Follow-up marker panel for is high homocysteine dangerous clinical sorting
그림 10: A cause-focused panel prevents over-treating the wrong pathway.

A vitamin pattern usually shows high homocysteine with low or borderline B12, high MMA, low RBC folate, macrocytosis or high RDW. A kidney pattern more often pairs homocysteine above 15–20 µmol/L with eGFR below 60, cystatin C elevation or albuminuria.

A medication pattern is diagnosed from timing as much as chemistry. If homocysteine rose from 11 to 24 µmol/L after 18 months on a new anti-seizure drug, the time course matters more than a one-time folate result.

An inherited pattern is more likely when total homocysteine is above 100 µmol/L, methionine is abnormal, symptoms began young or relatives have early thrombotic disease. In those cases, urine amino acids, plasma methionine, specialist metabolic review and targeted genetic testing may be appropriate.

Repeat testing and sample handling: avoiding false alarms

A high homocysteine result should often be repeated fasting, with prompt sample processing, especially when the value is borderline or does not fit the clinical picture. Homocysteine can drift if whole blood sits before separation, and different assays may not match perfectly. Our 공복 혈액검사 가이드는 explains which results are most sensitive to preparation.

Sample handling workflow for is high homocysteine dangerous repeat testing
그림 11: Pre-analytic handling can turn a borderline result into a misleading flag.

For borderline values between 12 and 18 µmol/L, I prefer a repeat after an overnight fast, no heavy alcohol for 48 hours, and no hard endurance session the day before. This is not because fasting magically fixes risk; it reduces noise.

Sample delay matters because cellular metabolism can alter measured homocysteine after collection. Many labs separate plasma quickly or use chilled handling, but if a remote collection site delays processing by several hours, a small elevation may be less trustworthy.

Use the same lab when tracking change. A shift from 28 to 16 µmol/L after B12 therapy is clinically meaningful, but a shift from 14.8 to 13.9 µmol/L across two different platforms may simply be analytical variation; our 검사실 변동성 가이드는 covers this problem in detail.

How to lower homocysteine safely without missing the cause

Lowering homocysteine safely means treating the cause: B12 if MMA is high, folate if folate stores are low, B6 only when appropriate, kidney-risk management when eGFR is reduced, and medication review when timing fits. Typical supplement plans are reassessed after 8–12 weeks, not indefinitely escalated. For supplement planning, start with our B12 dosing guide.

Nutrition and supplement scene asking is high homocysteine dangerous to lower
그림 12: Treatment should match the pathway, not just chase a lower number.

Common clinician-supervised regimens include oral B12 1,000 mcg/day, folic acid or methylfolate 400–1,000 mcg/day, and B6 10–50 mg/day when intake is low or medications justify it. I avoid casual chronic B6 megadosing because neuropathy risk can mimic the symptoms we are trying to fix.

Toole et al. reported in the 2004 JAMA VISP trial that high-dose B vitamins lowered homocysteine after stroke but did not clearly reduce recurrent vascular events compared with lower-dose vitamins. That trial is one reason I tell patients: lower the number when the cause is real, but do not mistake homocysteine for the whole cardiovascular risk story.

Diet still matters, especially for people with low folate intake. Leafy greens, legumes, citrus, eggs, dairy or fortified foods can support the pathway, but the best form depends on B12 status and pregnancy plans; our folate versus folic acid guide 그 미묘한 차이를 설명합니다.

How Kantesti AI interprets homocysteine in context

Kantesti AI interprets homocysteine by comparing the value with vitamin markers, kidney markers, CBC indices, thyroid tests, medication context and prior trends. 칸테스티는 AI 바이오마커 해석 플랫폼 used by people in 127+ countries, and our goal is to flag plausible patterns for discussion with a clinician, not replace diagnosis. The methodology is described in our 기술 가이드.

AI pattern review for is high homocysteine dangerous across related biomarkers
그림 13: Pattern recognition helps distinguish vitamin, kidney, medication and inherited clues.

If homocysteine is 23 µmol/L, B12 is 310 pg/mL, MMA is high and MCV is 96 fL, Kantesti’s neural network treats that as a likely functional B12 pattern. If the same homocysteine value appears with eGFR 48 and normal MMA, the priority shifts toward kidney-related interpretation.

We also look for contradictions. A patient with homocysteine 17 µmol/L, normal active B12, normal folate, normal eGFR and a delayed sample note may need a repeat test more than a supplement stack.

Our clinical review process is overseen by physicians and scientists, including my own editorial checks as Thomas Klein, MD. For readers who want the limits as well as the strengths of automation, our AI 해석 가이드 explains where human medical judgment still wins.

Kantesti 연구 논문 및 의학적 검토 메모

As of June 11, 2026, homocysteine interpretation at Kantesti is reviewed as part of a broader medical-safety workflow that prioritizes trend context, unit accuracy and clinician follow-up prompts. This article was written under physician editorial oversight and aligns with our documented validation approach in clinical oversight.

Editorial review desk for is high homocysteine dangerous medical references
그림 14: Medical review connects published evidence with safe patient-facing interpretation.

Kantesti’s research library includes formal DOI-indexed work on symptom interpretation, patient education structure and multilingual health guidance. Those publications are not homocysteine trials, but they document the editorial and engineering standards we apply when explaining complex lab patterns across 75+ languages.

Kantesti LTD. (2026). Diarrhea After Fasting, Black Specks in Stool & GI Guide 2026. Figshare. DOI: 10.6084/m9.figshare.31438111. ResearchGate: https://www.researchgate.net/search/publication?q=Diarrhea%20After%20Fasting%20Black%20Specks%20in%20Stool%20GI%20Guide%202026. Academia.edu: https://www.academia.edu/search?q=Diarrhea%20After%20Fasting%20Black%20Specks%20in%20Stool%20GI%20Guide%202026. Related Kantesti page: GI guide 2026.

Kantesti LTD. (2026). 여성 건강 가이드: 배란, 폐경 및 호르몬 증상. Figshare. DOI: 10.6084/m9.figshare.31830721. ResearchGate: https://www.researchgate.net/search/publication?q=Women's%20Health%20Guide%20Ovulation%20Menopause%20Hormonal%20Symptoms. Academia.edu: https://www.academia.edu/search?q=Women's%20Health%20Guide%20Ovulation%20Menopause%20Hormonal%20Symptoms. Related Kantesti page: 여성 건강 가이드는.

For medical accountability, Kantesti’s content is reviewed against physician-led safety standards and updated when guideline interpretation changes. You can review the clinicians behind that process on our 의료 자문 위원회.

자주 묻는 질문

다른 모든 것이 정상이라면 고(高) 호모시스테인은 위험한가요?

다른 일상 검사들이 정상이어도 고(高) 호모시스테인은 여전히 중요할 수 있는데, 혈청 B12, CBC 및 크레아티닌은 초기 기능적 결핍이나 미묘한 신장 청소율 변화(신장 배설 변화)를 놓칠 수 있기 때문입니다. 15 µmol/L를 초과해 지속되는 값은 검토가 필요하며, 30 µmol/L를 초과하는 값은 보다 구조화된 추적 검사 패널이 필요합니다. 가장 유용한 다음 검사는 활성 B12 또는 홀로트랜스코발라민, 메틸말론산, RBC 엽산, eGFR, 시스타틴 C, 소변 ACR 및 TSH입니다.

호모시스테인의 어느 수치가 위험한가요?

일반적인 성인 호모시스테인 범위는 약 5–15 µmol/L이며, 15–30 µmol/L는 보통 경미하게 상승한 것으로 부릅니다. 30–100 µmol/L 범위는 더 우려되며 비타민, 신장, 갑상선 및 약물 검토를 통해 반복 측정해야 합니다. 100 µmol/L를 초과하는 수치는 흔치 않으며, 심각한 B12 경로 장애, 유전성 호모시스테인 질환 또는 전문의 평가가 필요한 복합 대사 문제를 시사할 수 있습니다.

높은 호모시스테인 수치가 증상을 유발할 수 있나요?

고(高)호모시스테인은 그 자체로는 대개 직접적인 증상을 일으키지 않으므로 많은 사람이 검사 패널에서 이를 발견합니다. 증상은 대개 B12 결핍으로 인한 저림, 발의 작열감, 기억 변화 또는 빈혈처럼 기저 원인에서 비롯됩니다. 갑작스러운 한쪽 팔다리의 약화, 흉부 압박감, 종아리 부종 또는 갑작스러운 숨가쁨은 호모시스테인 결과와 무관하게 응급 증상으로 치료해야 합니다.

가장 흔한 고호모시스테인 원인은 무엇입니까?

가장 흔한 고호모시스테인 원인은 B12의 낮거나 흡수가 불량한 경우, 엽산 결핍, B6 섭취 부족, 신장 기능 저하, 갑상선기능저하증, 흡연 및 약물의 영향입니다. 메트포르민, 양성자 펌프 억제제, 항경련제, 메토트렉세이트, 레보도파 및 아산화질소 노출은 모두 기여할 수 있습니다. 유전성 질환은 덜 흔하지만 수치가 100 µmol/L를 초과하거나 가족 내에서 조기 혈전이 발생한 경우에는 더 가능성이 높아집니다.

호모시스테인을 낮추면 심장마비를 예방할 수 있나요?

비타민으로 호모시스테인을 낮추는 것이 모든 성인에서 심근경색을 신뢰성 있게 예방하지는 못하지만, 높은 호모시스테인은 혈관 위험과 연관되어 있다. VISP 및 HOPE-2와 같은 대규모 임상시험에서는 호모시스테인을 낮췄으나, 치료받은 모든 군에서 주요 심혈관 사건의 전반적인 명확한 감소가 나타나지는 않았다. 실제 결핍 또는 대사 원인이 발견된 경우에는 치료가 여전히 적절하지만, 호모시스테인은 ApoB, LDL-C, 혈압, 당뇨병 지표, 신장 기능 및 흡연 상태와 함께 해석해야 한다.

고(高) 호모시스테인 수치가 나온 뒤 어떤 검사를 요청해야 하나요?

After high homocysteine, the usual follow-up tests are active B12 or holotranscobalamin, methylmalonic acid, serum or RBC folate, CBC with MCV and RDW, creatinine with eGFR, cystatin C, urine albumin-creatinine ratio and TSH. If the result is above 100 µmol/L, clinicians may add plasma methionine, urine amino acids and specialist metabolic testing. Medication history and sample handling details are part of the workup because they can change the interpretation.

호모시스테인을 낮추는 데 얼마나 걸리나요?

호모시스테인은 올바른 결핍 또는 약물 관련 원인을 교정하면 8–12주 내에 종종 호전됩니다. 경구 비타민 B12 1,000mcg/일과 엽산 400–1,000mcg/일은 흔히 임상의가 감독하는 범위이지만, 용량은 원인과 환자 상황에 따라 달라집니다. 가능하면 동일한 검사실의 검사로 재확인하십시오. 1–2µmol/L 정도의 작은 변화는 실제 호전이 아니라 검사(분석) 변동을 반영할 수 있기 때문입니다.

오늘 AI 기반 혈액검사 분석 받기

즉시 정확한 검사 분석을 위해 Kantesti를 신뢰하는 전 세계 200만 명 이상의 사용자와 함께하세요. 혈액검사 결과를 업로드하고 몇 초 만에 15,000+ 바이오마커에 대한 포괄적인 해석을 받아보세요.

📚 참고된 연구 출판물

1

Klein, T., Mitchell, S., & Weber, H. (2026). 단식 후 설사, 대변에 검은 반점이 나타나는 경우 및 2026년 위장 질환 가이드. Kantesti AI 의학 연구.

2

Klein, T., Mitchell, S., & Weber, H. (2026). 여성 건강 가이드: 배란, 폐경 및 호르몬 증상. Kantesti AI 의학 연구.

📖 외부 의학 참고문헌

3

Homocysteine Studies Collaboration (2002). 호모시스테인과 허혈성 심장질환 및 뇌졸중의 위험: 메타분석. JAMA.

4

Toole JF et al. (2004). Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the VISP randomized controlled trial. JAMA.

5

Lonn E 등 (2006). 혈관 질환에서 엽산과 비타민 B로 호모시스테인 낮추기. 뉴잉글랜드 의학저널(NEJM).

200만+분석된 테스트
127+국가
75+언어

⚕️ 의료 면책 조항

E-E-A-T 신뢰 신호

경험

의사가 주도하는 검사 해석 워크플로 임상 검토.

📋

전문적 지식

임상 맥락에서 바이오마커가 어떻게 거동하는지에 대한 검사실 의학 중심.

👤

권위

Dr. Thomas Klein이 작성했으며 Dr. Sarah Mitchell과 Prof. Dr. Hans Weber가 검토했습니다.

🛡️

신뢰성

경고를 줄이기 위한 명확한 후속 경로가 포함된 근거 기반 해석.

🏢 칸테스티 LTD 잉글랜드 & 웨일스에 등록 · 회사 번호. 17090423 런던, 영국 · 칸테스티.넷
blank
Prof. Dr. Thomas Klein에 의해

Thomas Klein 박사는 Kantesti AI의 최고 의료 책임자(CMO)로 재직 중인 보드 인증 임상 혈액종양내과 전문의입니다. 실험실 의학 분야에서 15년 이상의 경험을 보유하고 있으며, 혈액검사 결과의 AI 지원 해석에 큰 관심을 가지고 있습니다. 그는 새로운 기술을 일상적인 임상 진료와 연결하기 위해 노력합니다. 그의 관심 분야에는 생체표지자 분석, 임상 의사결정 지원 연구, 인구집단별 기준 범위 최적화가 포함됩니다. CMO로서 그는 플랫폼의 내부 벤치마킹에 대한 임상적 의견을 제공하고, Kantesti의 교육 보고서에 대한 의학적 품질에 대해 임상적 감독을 제공합니다.

답글 남기기

이메일 주소는 공개되지 않습니다. 필수 필드는 *로 표시됩니다